Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University 14 years ago Research & Clinical Trial Webinars,Webinars You may also like Webinar: Understanding BiPAP – Why It’s Needed, What Gets in the Way, and How to Increase Compliance 5 months ago Care Webinars,Webinars bipap Webinar: Capricor – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy 7 months ago Research & Clinical Trial Webinars,Webinars capricor,cardiac,deramiocel Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies 8 months ago Research & Clinical Trial Webinars,Webinars edgewise,sevasemten Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 8 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 8 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 59:44 Webinar: Steroids and Stress Dosing – Understanding the Updated PJ Nicholoff Steroid Protocol 9 months ago Care Webinars,Webinars emergency care,PJ's Protocol,steroids 01:06:15 Webinar: Discover the Power of Your Data – The Duchenne Registry 9 months ago Webinars The Duchenne Registry 1:20:43 Webinar: Sarepta Therapeutics – Duchenne Gene Therapy Update 10 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta «1234…28»Page 2 of 28